Urothelial Carcinoma
📧 Sign up to get email alerts when something new happens for Urothelial Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Bintrafusp Alfa (M7824) and PDS01ADC Alone and in Combination With Stereotactic Body Radiation Therapy (SBRT) in Adults With Metastatic Non-Prostate Genitourinary Malignancies [Phase 1]
This Phase 1 clinical trial update evaluates Bintrafusp alfa (M7824) and PDS01ADC alone and in combination with SBRT in adults with metastat…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Anti-PD-1 mAb Plus Metabolic Modulator in Solid Tumor Malignancies [Phase 2]
Phase 2 clinical trial evaluating a PD-1–blocking monoclonal antibody in combination with a metabolic modulator for several solid tumors is …
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Detection and Risk Stratification in Veterans Presenting With Microscopic Hematuria
This ongoing clinical trial from Pacific Edge Limited aims to improve detection and risk stratification for urothelial carcinoma in veterans…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: DS3201 and Ipilimumab for the Treatment of Metastatic Prostate, Urothelial and Renal Cell Cancers [Phase 1]
Phase 1 clinical trial update evaluating DS3201 in combination with ipilimumab for metastatic prostate, urothelial, and renal cell cancers.
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Ceralasertib (AZD6738) Alone and in Combination With Olaparib or Durvalumab in Patients With Solid Tumors [Phase 2]
Phase 2 clinical trial update of ceralasertib (AZD6738) alone and in combination with olaparib or durvalumab in various solid tumors; the st…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: A Multicenter, Non-interventional, Descriptive Study to Assess Assay Concordance of HER2 IHC Testing in Chinese Pan-tumor Patients
AstraZeneca is conducting a multicenter, non-interventional study in Chinese pan-tumor patients to assess concordance of HER2 IHC testing ac…
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors [Phase 2]
This clinical trial update outlines a Phase 2 study assessing the combination of nivolumab, ipilimumab, and cabozantinib for various rare ge…
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: Testing the Addition of the Anti-cancer Drug, Cabozantinib, to the Usual Immunotherapy Treatment, Avelumab, in Patients With Metastatic Urothelial Cancer, MAIN-CAV Study [Phase 3]
A Phase 3 trial (MAIN-CAV) is evaluating the addition of cabozantinib to the immunotherapy drug avelumab for metastatic urothelial cancer, w…
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2 [Phase 2]
A Phase 2 clinical trial evaluating Disitamab Vedotin alone or with Pembrolizumab for HER2-expressing urothelial carcinoma is currently recr…
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: Study of DCC-2812 in Participants With Advanced Genitourinary Cancers [Phase 1]
This clinical trial update reports that a Phase 1 study of DCC-2812 in advanced genitourinary cancers (renal cell carcinoma, urothelial carc…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer [Phase 1, Phase 2]
The document describes a Pfizer-sponsored clinical trial investigating PF-08634404 alone or in combination with Enfortumab Vedotin for uroth…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: A Study of FX-909 in Patients With Advanced Solid Malignancies, Including Advanced Urothelial Carcinoma [Phase 1]
Phase 1 trial update for FX-909 in patients with advanced urothelial carcinoma; the study is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: A Study Comparing BL-B01D1 With Chemotherapy of Physician's Choice in Patients With Recurrent or Metastatic Urothelial Carcinoma(PANKU-Bladder01) [Phase 3]
An ongoing Phase 3 trial comparing BL-B01D1 to physician's choice chemotherapy in patients with recurrent or metastatic urothelial carcinoma…
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: Intravesical GEM/DOCE for HR BCG-Unresponsive NMIBC [Phase 2]
Phase 2 clinical trial evaluating intravesical gemcitabine and docetaxel for high-risk, BCG-unresponsive non-muscle-invasive bladder cancer;…
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: A Study of BMS-986504 With Standard-of-Care Therapy for People With Solid Tumor Cancer [Phase 1]
Phase 1 clinical trial update for BMS-986504 in combination with standard-of-care therapy for solid tumors, including diffuse pleural mesoth…
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: BEACON-1: Study of AVZO-103 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Urothelial Cancer or Other Solid Tumors (AVZO-103-1001) [Phase 1, Phase 2]
Phase 1/2 clinical trial update for AVZO-103 as a single agent and in combination therapy for locally advanced or metastatic urothelial carc…
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: A Study of GEN1106 in Participants With Solid Tumors [Phase 1]
Phase 1 clinical trial update for GEN1106 in solid tumors, with a focus on urothelial carcinoma, currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: A Study of HLX18 vs. OPDIVO® in Multiple Resected Solid Tumors [Phase 1]
Phase 1 trial comparing HLX18 to nivolumab (Opdivo) in patients with multiple resected solid tumors, including esophageal/gastric cardia can…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: A Study Comparing the Combination of Pembrolizumab and Sacituzumab Govitecan Versus Standard of Care in the Treatment of Advanced Urothelial Cancer [Phase 3]
This Phase 3 trial is evaluating pembrolizumab plus sacituzumab govitecan versus standard of care for locally advanced, unresectable, or met…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: ARID1A and/or KDM6A Mutation and CXCL13 Expression [Phase 2]
Phase 2 clinical trial update from MD Anderson investigating ARID1A and/or KDM6A mutation status and CXCL13 expression in urothelial cancers…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: Continued Access Study for Participants Deriving Benefit in Pfizer-Sponsored Avelumab Parent Studies That Are Closing [Phase 3]
This trial update describes a continued access study for participants who benefit from Pfizer-sponsored avelumab parent studies that are clo…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: A Study to Survey Adults in South Korea With Cancer Who Receive PADCEV Injection
Astellas Korea is recruiting adults in South Korea for a survey study of cancer patients who receive PADCEV injections.
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Comparing the New Anti-cancer Drug Eribulin With Chemotherapy Against the Usual Chemotherapy Alone in Metastatic Urothelial Cancer [Phase 3]
Phase 3 clinical trial update evaluating eribulin plus standard chemotherapy versus standard chemotherapy alone for metastatic urothelial ca…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Testing the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial Cancer [Phase 1]
This Clinical Trial Update describes a Phase 1 study evaluating the addition of BAY 1895344 to standard chemotherapy (cisplatin or cisplatin…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Testing Combination Erdafitinib and Enfortumab Vedotin in Metastatic Bladder Cancer After Treatment With Chemotherapy and Immunotherapy [Phase 1]
A Phase 1 clinical trial is investigating the combination of Erdafitinib and Enfortumab Vedotin for metastatic bladder/urothelial cancers af…